Screen Pregnant Women for Syphilis, Ob-Gyn Group Advises
By Dennis Thompson HealthDay Reporter
FRIDAY, April 19, 2024 -- All expecting mothers should get a blood test for syphilis three times during pregnancy, new guidance issued by the American College of Obstetricians and Gynecologists recommends.
The practice advisory calls on doctors to test for syphilis at a pregnant woman’s first prenatal care visit, then again during the third trimester and at birth.
The advisory comes in response to a dramatic increase in syphilis rates among pregnant women and newborns.
Previously, ACOG recommended risk-based testing in the third trimester only for women living in communities with high rates of syphilis or women at high risk of becoming infected during pregnancy.
Syphilis can damage the heart and brain and cause blindness, deafness and paralysis unless it’s treated. When transmitted during pregnancy, it can cause miscarriage, lifelong health problems and infant death.
In February, the U.S. Centers for Disease Control and Prevention reported that maternal syphilis rates had tripled in recent years.
More than 10,000 women who gave birth in 2022 had syphilis, up from about 3,400 cases in 2016, the CDC found.
The ACOG advisory paints an even more dire picture, saying that U.S. rates of babies born infected with syphilis had increased by 755% between 2012 and 2021.
“There has been a near eightfold increase in congenital syphilis cases in the last decade or more, and from a public health perspective, we recognize that obstetrician–gynecologists and other obstetric care clinicians play a critical role,” said Dr. Christopher Zahn, ACOG’s interim CEO and chief of clinical practice and health equity and quality.
Notably, two in five infants born with syphilis had moms who didn’t receive any prenatal care, the advisory said.
“Therefore, it is important to make any health care encounter during pregnancy -- including those in emergency departments, jails, syringe service programs and maternal and child health programs -- an opportunity to screen for syphilis,” the advisory reads.
About 88% of syphilis cases in newborns could be prevented with timely screening and treatment, ACOG said.
“Timely diagnosis and treatment are key to reducing syphilis rates, and yet we are currently facing several challenges, including treatment shortages, lack of access to prenatal care and the stigma that surrounds sexually transmitted infections,” Zahn said in an ACOG news release. “Congenital syphilis can have devastating effects. We know that a majority of cases can be prevented, so additional routine screening during pregnancy is one important step that clinicians can take that could potentially be lifesaving."
Sources
- American College of Obstetricians and Gynecologists, news release, April 18, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Bird Flu Infection Confirmed in a Pig for First Time in U.S.
THURSDAY, Oct. 31, 2024 -- Amid an ongoing outbreak of bird flu in poultry and dairy cows in the United States, a case of H5N1 has now been confirmed for the first time in a...
Diagnostic Device Spots Malaria Without Need for Blood Sample
THURSDAY, Oct. 31, 2024 -- Scans using lasers and ultrasound can pick up signs of a malaria infection through the skin, without the need for a blood draw, Yale researchers...
Check Your Cabinet: Some COVID Test Expiration Dates Have Been Extended, FDA Says
THURSDAY, Oct. 31, 2024 -- Don’t automatically throw out that old COVID-19 at-home test you just came across in your medicine cabinet. It might still be good, according to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.